PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,026,000 | -0.4% | 2,000,000 | 0.0% | 0.06% | +14.8% |
| Q1 2022 | $2,035,000 | -3.1% | 2,000,000 | 0.0% | 0.05% | -18.2% |
| Q4 2021 | $2,100,000 | +0.2% | 2,000,000 | 0.0% | 0.07% | -18.5% |
| Q3 2021 | $2,095,000 | -2.8% | 2,000,000 | 0.0% | 0.08% | -12.0% |
| Q2 2021 | $2,155,000 | -6.3% | 2,000,000 | 0.0% | 0.09% | -37.8% |
| Q1 2021 | $2,300,000 | -11.5% | 2,000,000 | 0.0% | 0.15% | -22.9% |
| Q4 2020 | $2,598,000 | +14.7% | 2,000,000 | 0.0% | 0.19% | -36.4% |
| Q3 2020 | $2,266,000 | -2.4% | 2,000,000 | 0.0% | 0.30% | -14.0% |
| Q2 2020 | $2,321,000 | – | 2,000,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
| PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
| Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
| Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
| LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |